Join Us ABOUT US At G2V, we envision a future where health care uses genomics to improve human health equitably. We work towards this vision in the following ways: We conduct biomedical research to determine the role of genetic and genomic technologies in improving the care and health outcomes of Veterans and other patients. Our … Continued
Publications
2023
The GenoVA study: Equitable implementation of a pragmatic randomized trial of polygenic-risk scoring in primary care
The American Journal of Human Genetics
Nov 2023
Perceived benefits and barriers to implementing precision preventive care: Results of a national physician survey
European Journal of Human Genetics
Feb 2023
Primary care physician use of patient race and polygenic risk scores in medical decision-making
Genetics in Medicine
Feb 2023
Navigating the uncertainty of precision cancer screening: The role of shared decision-making
Patient Education and Counseling Innovation
Jan 2023
2022
Performance of EHR classifiers for patient eligibility in a clinical trial of precision medicine
Contemporary Clinical Trials
Sep 2022
2021
A cost-consequence analysis of preemptive SLCO1B1 testing for statin myopathy risk compared to usual care
Journal of Personalized Medicine
Oct 2021
The role of SLCO1B1 genotyping in lowering cardiovascular risk
Pharmacogenomics
Jul 2021
2020
2019
Pragmatic trials in genomic medicine: The Integrating Pharmacogenetics in Clinical Care (I-PICC) study
Clinical and Translational Science
Dec 2019
2018
Impact of SLCO1B1 pharmacogenetic testing on patient and healthcare outcomes: A systematic review
Clinical Pharmacology & Therapeutics
Aug 2018